LentiBlast Premium is a novel patented chemical composition that increases lentiviral infection and transduction efficiency in any type of cells, adherent or in suspension, primary or cell lines. The properties of this reagent allow simultaneously neutralizing electrostatic repulsions between membrane and viral particles and enhancing viral fusion with cell membrane. Due to a favorable membrane permeable effect limiting the transmembrane potential changes, LentiBlast Premium is non-toxic and totally compatible with cell viability. Perfect for enhancing lentiviral transduction in CD34+ hematopoietic stem cells, T lymphocytes as well as any other cells. It is ideal to increase R&D, preclinical and clinical transduction protocols for ex-vivo gene therapies and CAR-T cell therapies.
- Increase lentivirus infection efficiency for hard-to-transduce cells: The right solution for Stem cells, Primary T cells
- Save effort & money: Achieve same transduction results with a lower viral titer
- Maximize Cell Viability: Non-toxic